Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

WARREN CONWAY

Allopathic & Osteopathic Physicians Family Medicine

NPI
1245290717
CMS profile
55844
Location
SAN ANGELO, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$1,630.95

109 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,630.95 109

By paying entity

PY2021 · entire year · sorted by reported total

Page 3 of 3; records 101–109 of 109 matching records. This page contains 9 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

WARREN CONWAY

NPI 1245290717 · CMS profile ID 55844

Allopathic & Osteopathic Physicians / Family Medicine

SAN ANGELO, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 3; records 101–109 of 109 matching records. This page contains 9 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1245290717?year=2021&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
WARREN CONWAY, NPI 1245290717, CMS profile ID 55844. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–109 of 109 matching records. This page contains 9 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1245290717?year=2021&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). WARREN CONWAY, NPI 1245290717, CMS profile ID 55844. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–109 of 109 matching records. This page contains 9 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1245290717?year=2021&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
WARREN CONWAY, NPI 1245290717, CMS profile ID 55844, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 3; records 101–109 of 109 matching records. This page contains 9 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1245290717?year=2021&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

109 matching records · $1,630.95 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 109 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–109 of 109.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
AbbVie Inc. $13.2201/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794282989 CMS
Biohaven Pharmaceuticals, Inc. $21.6201/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852467139 CMS
Takeda Pharmaceuticals U.S.A., Inc. $23.6801/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 819897927 CMS
Takeda Pharmaceuticals U.S.A., Inc. $3.7101/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 819897929 CMS
Novo Nordisk Inc $19.2201/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811423981 CMS
Takeda Pharmaceuticals U.S.A., Inc. $25.9601/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 819897923 CMS
Merck Sharp & Dohme Corporation $11.4301/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848542403 CMS
Novo Nordisk Inc $21.9501/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 810630395 CMS
Lilly USA, LLC $22.0101/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818822907 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,128.93 78
PY2020 $1,543.05 93
PY2021 $1,630.95 109
PY2022 $1,247.48 84
PY2023 $5,005.76 81
PY2024 $939.04 55
PY2025 $838.41 55

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $914,902.95 46
PY2024 Principal investigator $518,054.69 68
PY2023 Principal investigator $367,934.55 28

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

46 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Bavarian Nordic A/S $17,014.50 12/24/2025 Non-covered Recipient Entity
QCare Site Services Inc.
WEV-MVA-002 No dispute reported 06/30/2026 1250214542
Principal investigator 1 Bavarian Nordic A/S $127.00 12/22/2025 Non-covered Recipient Entity
QCare Site Services Inc.
WEV-MVA-002 No dispute reported 06/30/2026 1250214540
Principal investigator 1 ModernaTX, Inc. $5,059.05 12/17/2025 Non-covered Recipient Entity
LSB RESEARCH GROUP LLC
A Study to Investigate the Immunogenicity and Safety of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in High-risk Adults No dispute reported 06/30/2026 1252959915
Principal investigator 1 ModernaTX, Inc. $74,746.80 12/17/2025 Non-covered Recipient Entity
QCARE SITE SERVICES INC
A Study of mRNA-1647 Cytomegalovirus Vaccine in Healthy Participants 9 to 15 Years of Age and Participants 16 to 25 Years of Age No dispute reported 06/30/2026 1252959975
Principal investigator 1 ModernaTX, Inc. $972.10 12/01/2025 Non-covered Recipient Entity
LSB RESEARCH GROUP LLC
A Study to Investigate the Immunogenicity and Safety of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in High-risk Adults No dispute reported 06/30/2026 1252959917
Principal investigator 1 Bavarian Nordic A/S $12,559.95 11/25/2025 Non-covered Recipient Entity
QCare Site Services Inc.
WEV-MVA-002 No dispute reported 06/30/2026 1250214538
Principal investigator 1 Bavarian Nordic A/S $3,058.05 11/03/2025 Non-covered Recipient Entity
QCare Site Services Inc.
WEV-MVA-002 No dispute reported 06/30/2026 1250214536
Principal investigator 1 ModernaTX, Inc. $486.05 10/22/2025 Non-covered Recipient Entity
LSB RESEARCH GROUP LLC
A Study to Investigate the Immunogenicity and Safety of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in High-risk Adults No dispute reported 06/30/2026 1252959941
Principal investigator 1 Bavarian Nordic A/S $70,410.20 10/10/2025 Non-covered Recipient Entity
QCare Site Services Inc.
WEV-MVA-002 No dispute reported 06/30/2026 1250214534
Principal investigator 1 ModernaTX, Inc. $6,328.80 10/08/2025 Non-covered Recipient Entity
QCARE SITE SERVICES INC
A Study of mRNA-1647 Cytomegalovirus Vaccine in Healthy Participants 9 to 15 Years of Age and Participants 16 to 25 Years of Age No dispute reported 06/30/2026 1252959965
Principal investigator 1 ModernaTX, Inc. $4,860.50 09/24/2025 Non-covered Recipient Entity
LSB RESEARCH GROUP LLC
A Study to Investigate the Immunogenicity and Safety of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in High-risk Adults No dispute reported 06/30/2026 1252959949
Principal investigator 1 ModernaTX, Inc. $486.05 09/02/2025 Non-covered Recipient Entity
LSB RESEARCH GROUP LLC
A Study to Investigate the Immunogenicity and Safety of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in High-risk Adults No dispute reported 06/30/2026 1252959971
Principal investigator 1 Bavarian Nordic A/S $23,431.75 08/25/2025 Non-covered Recipient Entity
QCare Site Services Inc.
WEV-MVA-002 No dispute reported 06/30/2026 1250214532
Principal investigator 1 Bavarian Nordic A/S $115,058.30 08/18/2025 Non-covered Recipient Entity
QCare Site Services Inc.
WEV-MVA-002 No dispute reported 06/30/2026 1250214530
Principal investigator 1 Bavarian Nordic A/S $3,198.00 08/15/2025 Non-covered Recipient Entity
QCare Site Services Inc.
WEV-MVA-002 No dispute reported 06/30/2026 1250214528
Principal investigator 1 ModernaTX, Inc. $56,012.85 08/01/2025 Non-covered Recipient Entity
QCARE SITE SERVICES INC
A Study of mRNA-1647 Cytomegalovirus Vaccine in Healthy Participants 9 to 15 Years of Age and Participants 16 to 25 Years of Age No dispute reported 06/30/2026 1252959935
Principal investigator 1 ModernaTX, Inc. $486.05 08/01/2025 Non-covered Recipient Entity
LSB RESEARCH GROUP LLC
A Study to Investigate the Immunogenicity and Safety of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in High-risk Adults No dispute reported 06/30/2026 1252959957
Principal investigator 1 Bavarian Nordic A/S $220,382.90 07/23/2025 Non-covered Recipient Entity
QCare Site Services Inc.
WEV-MVA-002 No dispute reported 06/30/2026 1250214526
Principal investigator 1 ModernaTX, Inc. $4,374.45 07/02/2025 Non-covered Recipient Entity
LSB RESEARCH GROUP LLC
A Study to Investigate the Immunogenicity and Safety of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in High-risk Adults No dispute reported 06/30/2026 1252959945
Principal investigator 1 ModernaTX, Inc. $34,573.50 06/18/2025 Non-covered Recipient Entity
QCARE SITE SERVICES INC
A Study of mRNA-1647 Cytomegalovirus Vaccine in Healthy Participants 9 to 15 Years of Age and Participants 16 to 25 Years of Age No dispute reported 06/30/2026 1252959977
Principal investigator 1 Bavarian Nordic A/S $75,829.95 06/06/2025 Non-covered Recipient Entity
QCare Site Services Inc.
WEV-MVA-002 No dispute reported 06/30/2026 1250214524
Principal investigator 1 ModernaTX, Inc. $972.10 05/28/2025 Non-covered Recipient Entity
LSB RESEARCH GROUP LLC
A Study to Investigate the Immunogenicity and Safety of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in High-risk Adults No dispute reported 06/30/2026 1252959925
Principal investigator 1 Bavarian Nordic A/S $571.00 05/23/2025 Non-covered Recipient Entity
QCare Site Services Inc.
WEV-MVA-002 No dispute reported 06/30/2026 1250214522
Principal investigator 1 ModernaTX, Inc. $2,372.75 04/23/2025 Non-covered Recipient Entity
LSB RESEARCH GROUP LLC
A Study to Investigate the Immunogenicity and Safety of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in High-risk Adults No dispute reported 06/30/2026 1252959967
Principal investigator 1 ModernaTX, Inc. $94,510.80 04/16/2025 Non-covered Recipient Entity
QCARE SITE SERVICES INC
A Study of mRNA-1647 Cytomegalovirus Vaccine in Healthy Participants 9 to 15 Years of Age and Participants 16 to 25 Years of Age No dispute reported 06/30/2026 1252959961
Principal investigator 1 ModernaTX, Inc. $1,215.00 04/16/2025 Non-covered Recipient Entity
QCARE SITE SERVICES INC
A Study of mRNA-1647 Cytomegalovirus Vaccine in Healthy Participants 9 to 15 Years of Age and Participants 16 to 25 Years of Age No dispute reported 06/30/2026 1252959963
Principal investigator 1 ModernaTX, Inc. $2,500.00 04/11/2025 Non-covered Recipient Entity
QCARE SITE SERVICES INC
A Study of mRNA-1647 Cytomegalovirus Vaccine in Healthy Participants 9 to 15 Years of Age and Participants 16 to 25 Years of Age No dispute reported 06/30/2026 1252959937
Principal investigator 1 ModernaTX, Inc. $3,344.85 03/21/2025 Non-covered Recipient Entity
LSB RESEARCH GROUP LLC
A Study to Investigate the Immunogenicity and Safety of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in High-risk Adults No dispute reported 06/30/2026 1252959955
Principal investigator 1 Bavarian Nordic A/S $11,363.00 03/19/2025 Non-covered Recipient Entity
QCare Site Services Inc.
WEV-MVA-002 No dispute reported 06/30/2026 1250214414
Principal investigator 1 ModernaTX, Inc. $1,350.00 02/26/2025 Non-covered Recipient Entity
LSB RESEARCH GROUP LLC
A Study to Investigate the Immunogenicity and Safety of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in High-risk Adults No dispute reported 06/30/2026 1252959919
Principal investigator 1 ModernaTX, Inc. $5,059.05 02/26/2025 Non-covered Recipient Entity
LSB RESEARCH GROUP LLC
A Study to Investigate the Immunogenicity and Safety of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in High-risk Adults No dispute reported 06/30/2026 1252959943
Principal investigator 1 ModernaTX, Inc. $1,701.00 02/26/2025 Non-covered Recipient Entity
LSB RESEARCH GROUP LLC
A Study to Investigate the Immunogenicity and Safety of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in High-risk Adults No dispute reported 06/30/2026 1252959959
Principal investigator 1 Eli Lilly and Company $9,696.00 02/25/2025 Non-covered Recipient Entity
QCARE SITE SERVICES INC
A STUDY OF DONANEMAB VERSUS PLACEBO IN PARTICIPANTS AT RISK FOR COGNITIVE AND FUNCTIONAL DECLINE OF ALZHEIMER'S DISEASE No dispute reported 06/30/2026 1187888528
Principal investigator 1 ModernaTX, Inc. $4,750.00 02/19/2025 Non-covered Recipient Entity
LSB RESEARCH GROUP LLC
A Study to Investigate the Immunogenicity and Safety of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in High-risk Adults No dispute reported 06/30/2026 1252959923
Principal investigator 1 ModernaTX, Inc. $1,950.00 02/19/2025 Non-covered Recipient Entity
LSB RESEARCH GROUP LLC
A Study to Investigate the Immunogenicity and Safety of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in High-risk Adults No dispute reported 06/30/2026 1252959929
Principal investigator 1 ModernaTX, Inc. $1,200.00 02/19/2025 Non-covered Recipient Entity
LSB RESEARCH GROUP LLC
A Study to Investigate the Immunogenicity and Safety of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in High-risk Adults No dispute reported 06/30/2026 1252959973
Principal investigator 1 ModernaTX, Inc. $375.00 02/14/2025 Non-covered Recipient Entity
LSB RESEARCH GROUP LLC
A Study to Investigate the Immunogenicity and Safety of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in High-risk Adults No dispute reported 06/30/2026 1252959921
Principal investigator 1 ModernaTX, Inc. $1,464.75 02/14/2025 Non-covered Recipient Entity
LSB RESEARCH GROUP LLC
A Study to Investigate the Immunogenicity and Safety of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in High-risk Adults No dispute reported 06/30/2026 1252959931
Principal investigator 1 ModernaTX, Inc. $750.00 02/14/2025 Non-covered Recipient Entity
LSB RESEARCH GROUP LLC
A Study to Investigate the Immunogenicity and Safety of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in High-risk Adults No dispute reported 06/30/2026 1252959939
Principal investigator 1 ModernaTX, Inc. $375.00 02/14/2025 Non-covered Recipient Entity
LSB RESEARCH GROUP LLC
A Study to Investigate the Immunogenicity and Safety of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in High-risk Adults No dispute reported 06/30/2026 1252959947
Principal investigator 1 ModernaTX, Inc. $2,146.50 02/14/2025 Non-covered Recipient Entity
LSB RESEARCH GROUP LLC
A Study to Investigate the Immunogenicity and Safety of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in High-risk Adults No dispute reported 06/30/2026 1252959953
Principal investigator 1 ModernaTX, Inc. $750.00 02/14/2025 Non-covered Recipient Entity
LSB RESEARCH GROUP LLC
A Study to Investigate the Immunogenicity and Safety of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in High-risk Adults No dispute reported 06/30/2026 1252959969
Principal investigator 1 ModernaTX, Inc. $337.50 02/12/2025 Non-covered Recipient Entity
LSB RESEARCH GROUP LLC
A Study to Investigate the Immunogenicity and Safety of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in High-risk Adults No dispute reported 06/30/2026 1252959933
Principal investigator 1 ModernaTX, Inc. $17,064.00 01/29/2025 Non-covered Recipient Entity
QCARE SITE SERVICES
A Study of mRNA-1647 Cytomegalovirus Vaccine in Healthy Participants 9 to 15 Years of Age and Participants 16 to 25 Years of Age No dispute reported 06/30/2026 1252959951
Principal investigator 1 Sekisui Diagnostics LLC $14,568.80 01/17/2025 Non-covered Recipient Entity
QCare Site Services, Inc.
Performance Evaluation of the Sekisui Acucy COVID-19 Test No dispute reported 06/30/2026 1241006244
Principal investigator 1 ModernaTX, Inc. $5,059.05 01/03/2025 Non-covered Recipient Entity
LSB RESEARCH GROUP LLC
A Study to Investigate the Immunogenicity and Safety of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in High-risk Adults No dispute reported 06/30/2026 1252959927